Market Cap

Zealand Pharma A/S Market Capitalization:

kr.66.94 Billion

DKK as of July 1, 2024

US$9.64 Billion

business Zealand Pharma A/S Company Profile

Zealand Pharma A/S Main Stock Listing

OMXC: ZEAL

Market Capitalization History of Zealand Pharma A/S

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $113.24 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $76.33 B
Marinomed Biotech AG $56.13 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $689.42 B
Novo Nordisk $622.07 B
UnitedHealth Group $487.54 B
Johnson & Johnson $353.05 B
AbbVie $301.60 B

Yearly evolution of Zealand Pharma A/S market cap

Date Market Cap YoY Change
Jan. 1, 2024 kr.21.50 B 95.55%
Jan. 1, 2023 kr.11.00 B 70.25%
Jan. 1, 2022 kr.6.46 B -37.86%
Jan. 1, 2021 kr.10.39 B -16.84%
Jan. 1, 2020 kr.12.50 B 162.17%
Jan. 1, 2019 kr.4.77 B -10.80%
Jan. 1, 2018 kr.5.35 B -14.26%
Jan. 1, 2017 kr.6.23 B -2.79%
Jan. 1, 2016 kr.6.41 B 46.78%
Jan. 1, 2015 kr.4.37 B 16.33%
Jan. 1, 2014 kr.3.76 B -23.44%
Jan. 1, 2013 kr.4.91 B 50.00%
Jan. 1, 2012 kr.3.27 B -8.57%
Jan. 1, 2011 kr.3.58 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +327.04%

$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Zealand Pharma A/S Categories

Denmark languages Healthcare languages Biotechnology
Denmark Healthcare Denmark Biotechnology

Stocks & Indices

Zealand Pharma A/S has the following listings and related stock indices.


Stock: OMXC: ZEAL

Stock: NASDAQ: ZEAL

Stock: FSX: 22ZA

Stock: OTC: ZLDPF

Stock: FSX: 22Z

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.